Farmers & Merchants Investments Inc. raised its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 4.2% in the 3rd quarter, Holdings Channel reports. The firm owned 59,622 shares of the healthcare conglomerate’s stock after buying an additional 2,426 shares during the quarter. UnitedHealth Group comprises 1.1% of Farmers & Merchants Investments Inc.’s portfolio, making the stock its 19th largest holding. Farmers & Merchants Investments Inc.’s holdings in UnitedHealth Group were worth $15,862,000 as of its most recent SEC filing.
A number of other hedge funds have also added to or reduced their stakes in the business. Welch Group LLC bought a new stake in UnitedHealth Group during the 2nd quarter valued at about $106,000. FNY Investment Advisers LLC bought a new stake in UnitedHealth Group during the 3rd quarter valued at about $106,000. Blue Chip Partners Inc. bought a new stake in UnitedHealth Group during the 2nd quarter valued at about $107,000. Northwest Wealth Management LLC bought a new stake in UnitedHealth Group during the 2nd quarter valued at about $117,000. Finally, Fort L.P. bought a new stake in UnitedHealth Group during the 2nd quarter valued at about $119,000. Institutional investors and hedge funds own 85.44% of the company’s stock.
NYSE UNH opened at $261.01 on Monday. The company has a current ratio of 0.69, a quick ratio of 0.75 and a debt-to-equity ratio of 0.61. The stock has a market cap of $251.22 billion, a price-to-earnings ratio of 25.92, a price-to-earnings-growth ratio of 1.50 and a beta of 0.78. UnitedHealth Group Inc has a one year low of $208.48 and a one year high of $272.81.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 EPS for the quarter, beating analysts’ consensus estimates of $3.30 by $0.11. The business had revenue of $56.56 billion for the quarter, compared to the consensus estimate of $56.34 billion. UnitedHealth Group had a net margin of 5.71% and a return on equity of 23.62%. The company’s revenue for the quarter was up 12.4% on a year-over-year basis. During the same quarter last year, the firm posted $2.66 EPS. On average, equities research analysts expect that UnitedHealth Group Inc will post 12.81 EPS for the current year.
A number of equities research analysts recently weighed in on UNH shares. Morgan Stanley lifted their price objective on shares of UnitedHealth Group from $277.00 to $278.00 and gave the company a “$255.42” rating in a report on Wednesday, July 18th. Citigroup lifted their price objective on shares of UnitedHealth Group from $275.00 to $288.00 and gave the company a “$255.42” rating in a report on Wednesday, July 18th. Royal Bank of Canada lifted their price objective on shares of UnitedHealth Group from $282.00 to $284.00 and gave the company a “$255.42” rating in a report on Wednesday, July 18th. Goldman Sachs Group reiterated a “buy” rating and set a $277.00 price objective on shares of UnitedHealth Group in a report on Tuesday, July 17th. Finally, Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $287.00 price objective for the company in a report on Sunday, July 15th. One equities research analyst has rated the stock with a hold rating, twenty-two have assigned a buy rating and one has issued a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $289.41.
In other UnitedHealth Group news, CEO Steven H. Nelson sold 8,142 shares of the firm’s stock in a transaction dated Thursday, September 13th. The shares were sold at an average price of $265.00, for a total transaction of $2,157,630.00. Following the transaction, the chief executive officer now owns 22,496 shares of the company’s stock, valued at approximately $5,961,440. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Steven H. Nelson sold 26,033 shares of the firm’s stock in a transaction dated Friday, September 7th. The shares were sold at an average price of $270.65, for a total transaction of $7,045,831.45. The disclosure for this sale can be found here. Insiders have sold a total of 79,568 shares of company stock worth $21,128,177 in the last three months. Insiders own 0.87% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
See Also: Conference Calls
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.